Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 19.67%

Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin is 19.67% for the year ending December 31, 2023, a -53.87% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 42.64%, a 11.52% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 38.23%, a 18.40% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 32.29%, a 6.89% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 30.21%, a -2.11% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years